← All Forte Biosciences, INC filings

Forte Biosciences, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
FBRX
Forte Biosciences, INC
DEF 14A: Forte Biosciences Sets Date for 2025 Annual Meeting, Outlines Key Proposals
Forte Biosciences announces its 2025 Annual Meeting of Stockholders to be held virtually on May 29, 2025, featuring proposals for director elections and ratification of the company's independent auditor.
NASDAQ
FBRX
Forte Biosciences, INC
DEF 14A: Forte Biosciences Seeks Stockholder Approval for Amended Equity Incentive Plan
Forte Biosciences is asking stockholders to approve an amended and restated 2021 Equity Incentive Plan to attract and retain talent.
NASDAQ
FBRX
Forte Biosciences, INC
DEF 14A: Forte Biosciences Seeks Stockholder Approval for Reverse Stock Split and Amended Equity Incentive Plan
Forte Biosciences is asking stockholders to approve a reverse stock split and an amended equity incentive plan at its upcoming annual meeting.